Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Adicet Bio stock | $12.87

Own Adicet Bio stock in just a few minutes.

Fact checked

Adicet Bio, Inc is an other business based in the US. Adicet Bio shares (ACET) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Adicet Bio

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Adicet Bio. Find the stock by name or ticker symbol: ACET. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Adicet Bio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$12.87, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Adicet Bio, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Adicet Bio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Adicet Bio share price

Use our graph to track the performance of ACET stocks over time.

Adicet Bio shares at a glance

Information last updated 2020-11-30.
Latest market closeUSD$12.87
52-week rangeUSD$6.02 - USD$21.4
50-day moving average USD$12.3888
200-day moving average USD$14.5743
Wall St. target priceUSD$28.25
PE ratio N/A
Dividend yield N/A (7.43%)
Earnings per share (TTM) N/A

Buy Adicet Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Forex
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, ETFs
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Bonds
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Adicet Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adicet Bio price performance over time

Historical closes compared with the close of $12.87 from 2020-12-09

1 week (2021-01-14) -4.10%
1 month (2020-12-22) -11.85%
3 months (2020-10-21) -1.76%
6 months (2020-07-21) 359.64%
1 year (2020-01-21) 763.76%
2 years (2019-01-18) 49.13%
3 years (2018-01-18) N/A
5 years (2016-01-18) N/A

Is Adicet Bio under- or over-valued?

Valuing Adicet Bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Adicet Bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Adicet Bio's PEG ratio

Adicet Bio's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.82. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Adicet Bio's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Adicet Bio financials

Revenue TTM USD$14.5 million
Gross profit TTM USD$995,000
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin -237.16%
Book value $5.969
Market capitalisation USD$241.5 million

TTM: trailing 12 months

Shorting Adicet Bio shares

There are currently 119,746 Adicet Bio shares held short by investors – that's known as Adicet Bio's "short interest". This figure is 10.3% down from 133,553 last month.

There are a few different ways that this level of interest in shorting Adicet Bio shares can be evaluated.

Adicet Bio's "short interest ratio" (SIR)

Adicet Bio's "short interest ratio" (SIR) is the quantity of Adicet Bio shares currently shorted divided by the average quantity of Adicet Bio shares traded daily (recently around 51393.13304721). Adicet Bio's SIR currently stands at 2.33. In other words for every 100,000 Adicet Bio shares traded daily on the market, roughly 2330 shares are currently held short.

However Adicet Bio's short interest can also be evaluated against the total number of Adicet Bio shares, or, against the total number of tradable Adicet Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adicet Bio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Adicet Bio shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Adicet Bio shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Adicet Bio.

Find out more about how you can short Adicet Bio stock.

Adicet Bio share dividends

We're not expecting Adicet Bio to pay a dividend over the next 12 months.

Have Adicet Bio's shares ever split?

Adicet Bio's shares were split on a 1:7 basis on 16 September 2020. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adicet Bio shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Adicet Bio shares which in turn could have impacted Adicet Bio's share price.

Adicet Bio overview

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors or T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Its products pipeline includes ADI-001, which is in Phase 1 clinical study to treat non-Hodgkin's lymphoma; and ADI-002 that is in Phase 1 clinical study for the treatment of hepatocellular carcinoma and other solid tumors. The company is based in Menlo Park, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site